Stifel Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Stifel Financial’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-31,422	Closed	-$49K	–	3414
2022 Q3	$49K	Buy	31,422 +9,750	+45%	+$22.1K	﹤0.01%	3185
2022 Q2	$44K	Hold	21,672	–	–	﹤0.01%	3239
2022 Q1	$50K	Buy	+21,672	New	+$67.6K	﹤0.01%	3308

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Stifel Financial's SRNE Position: Q4 2022 in Review

Stifel Financial sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2022, closing a stake of 31,422 shares — an estimated $49K sold.

Stifel Financial first reported a position in SRNE in Q1 2022 and held it in 3 quarters. The position peaked at $50K in Q1 2022. 221 funds tracked by Wall St. Rank hold SRNE as of Q4 2022.

Stifel Financial reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Stifel Financial sold 31,422 Sorrento Therapeutics, Inc. shares in Q4 2022, an estimated $49K.
Stifel Financial first reported a position in Sorrento Therapeutics, Inc. in Q1 2022 and held it in 3 quarters.
Stifel Financial's Sorrento Therapeutics, Inc. position peaked at $50K in Q1 2022.
221 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2022.

Based on Stifel Financial's 13F filing for Q4 2022, filed 13 Feb 2023.